Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person13
GOLDENWELL BIOTECH, INC.
Company
NKGen Biotech, Inc.
Company
Edesa Biotech, Inc.
Company
Krystal Biotech, Inc.
Company
XBiotech Inc.
Company
Fortress Biotech, Inc.
Company
Moleculin Biotech, Inc.
Company
PharmaCyte Biotech, Inc.
Company
ONCOLYTICS BIOTECH INC
Company
Vir Biotechnology, Inc.
Company
MAIA Biotechnology, Inc.
Company
PUMA BIOTECHNOLOGY, INC.
Company
Sana Biotechnology, Inc.
Company
Primary record3
GOLDENWELL BIOTECH, INC. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 8, 2026, the board of directors of Goldenwell Biotec
GOLDENWELL BIOTECH, INC. filed SCHEDULE 13D
on August 14, 2026. Ms. Zhou directly owns and has sole voting power and sole dispositive power with respect to all of the shares of common stock reported in this Schedule 13D as being beneficially owned by her. Except a
GOLDENWELL BIOTECH, INC. filed 8-K
Item 4.01 Changes in Registrant s Certifying Accountant (a) On September 27, 2026, Goldenwell Biotech, Inc. (the Company ) notified Michael Gillespie & Associates, PLLC ( Gillespie & Associates ), that the Company had di